[Edaily Starin YUN GI BACK Reporter] The music video for the group i-dle’s hit song “TOMBOY” has surpassed 400 million views, once again proving its global popularity. (Photo courtesy of Cube Entertainment) According to their agency, Cube Entertainment, i-dle’s “TOMBOY” music video surpassed 400 million views on YouTube on the 7th. With this achievement, i-dle now has their third music video to reach 400 million views, following “Queen” and “Nude.” “Tom Boy” is the title track from their first full-length album, *I Never Die*, released in 2022, and has established itself as one of iKID’s signature hits. At the time, it sparked a phenomenon by achieving a “Perfect All-Kill” on major domestic music charts and was recognized for both its artistic merit and mass appeal by topping Billboard’s list of “Best K-Pop Songs of 2022.” It is noteworthy that even now, four years after its release, the song continues to enjoy long-term popularity, steadily increasing its view count. It is widely regarded as having transcended a fleeting trend to become one of IZ*ONE’s signature pieces, garnering sustained interest from global fans. iKIDZ has music videos that have surpassed 200 million views—such as “Ratata” and “Oh My God”—as well as numerous videos with over 100 million views, including “Han,” “Ryan,” “Hwa,” “Super Lady,” and “Allergy.” Analysts note that, backed by this robust catalog, the group is demonstrating the sustained spending power of its global fanbase.
A virtual creator that doesn’t require a human actor has emerged. There is no pre-written script, nor is there an operator manipulating it in real time. Artificial intelligence (AI) hosts the broadcas…
“When you examine the kidneys of mice with polycystic kidney disease, you can see large cysts. However, after administering Udenafil, a reduction in the size of these cysts was visible even to the nak…
(Graphic: Generative AI)
During the first week of August (August 3–7), SK BIOPHARMACEUTICALS posted its best-ever quarterly earnings, driven by the growth of its new epilepsy drug “cenobamate.” Ad…